| Nayana P Dave, MD | |
|
1775 Dempster St Ste E592b, Park Ridge, IL 60068-1143 | |
| (847) 723-8080 | |
| Not Available |
| Full Name | Nayana P Dave |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 37 Years |
| Location | 1775 Dempster St Ste E592b, Park Ridge, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003841255 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 036-085251 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Advocate Lutheran General Hospital | Park ridge, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advocate Health And Hospitals Corporation | 7810800935 | 2422 |
News Archive
In a major breakthrough in cancer gene therapy, a Northwestern University researcher has endowed immune cells with the ability to specifically target metastatic prostate cancer in mice without causing the toxic immune suppression that has been associated with earlier forms of cancer gene therapy.
Researchers at Geisinger have found that a computer algorithm developed using echocardiogram videos of the heart can predict mortality within a year.
CEL-SCI Corporation announced today that its partner Teva Pharmaceuticals, a leading global pharmaceutical company, has concluded the Site Initiation Visit for the first Israeli clinical center in CEL-SCI's Phase III clinical trial for Multikine, the Company's flagship cancer immunotherapy.
Indiana University researchers say a little deception caused cyclists in their 4-kilometer time trial to up their performance even after they realized they had been tricked.
› Verified 6 days ago
| Entity Name | Advocate Health And Hospitals Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700824455 PECOS PAC ID: 7810800935 Enrollment ID: O20031106000064 |
News Archive
In a major breakthrough in cancer gene therapy, a Northwestern University researcher has endowed immune cells with the ability to specifically target metastatic prostate cancer in mice without causing the toxic immune suppression that has been associated with earlier forms of cancer gene therapy.
Researchers at Geisinger have found that a computer algorithm developed using echocardiogram videos of the heart can predict mortality within a year.
CEL-SCI Corporation announced today that its partner Teva Pharmaceuticals, a leading global pharmaceutical company, has concluded the Site Initiation Visit for the first Israeli clinical center in CEL-SCI's Phase III clinical trial for Multikine, the Company's flagship cancer immunotherapy.
Indiana University researchers say a little deception caused cyclists in their 4-kilometer time trial to up their performance even after they realized they had been tricked.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nayana P Dave, MD 29373 Network Pl, Chicago, IL 60673-1293 Ph: () - | Nayana P Dave, MD 1775 Dempster St Ste E592b, Park Ridge, IL 60068-1143 Ph: (847) 723-8080 |
News Archive
In a major breakthrough in cancer gene therapy, a Northwestern University researcher has endowed immune cells with the ability to specifically target metastatic prostate cancer in mice without causing the toxic immune suppression that has been associated with earlier forms of cancer gene therapy.
Researchers at Geisinger have found that a computer algorithm developed using echocardiogram videos of the heart can predict mortality within a year.
CEL-SCI Corporation announced today that its partner Teva Pharmaceuticals, a leading global pharmaceutical company, has concluded the Site Initiation Visit for the first Israeli clinical center in CEL-SCI's Phase III clinical trial for Multikine, the Company's flagship cancer immunotherapy.
Indiana University researchers say a little deception caused cyclists in their 4-kilometer time trial to up their performance even after they realized they had been tricked.
› Verified 6 days ago
Dr. Jason Nathaniel Macklis, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 Luther Ln Ste 2200, Park Ridge, IL 60068 Phone: 847-268-8577 | |
Mohammed Omer Ahmed Abdalla, Internal Medicine Medicare: Medicare Enrolled Practice Location: 850 Busse Hwy, Park Ridge, IL 60068 Phone: 847-759-4770 | |
Dr. Anand Ramadorai, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1550 N Northwest Hwy Ste 303, Park Ridge, IL 60068 Phone: 847-294-5160 | |
Dr. Patrick J Murphy, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 711 W Devon, Park Ridge, IL 60068 Phone: 847-696-3176 Fax: 847-696-2678 | |
Dr. Peter Vayalil, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1775 Dempster St Ste E592b, Park Ridge, IL 60068 Phone: 847-723-8080 | |
William D. Rhoades, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1775 Ballard Rd, Park Ridge, IL 60068 Phone: 847-318-2500 |